Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings.

Lisa VermuntGraciela Muniz-TerreraLea Ter MeulenColin VealKaj BlennowArchie CampbellIsabelle CarriéJulien DelrieuKarine FauriaGema Huesa RodríguezSilvia IngalaNatalie JenkinsJosé Luis MolinuevoPierre-Jean OussetDavid PorteousNiels D PrinsAlina SolomonBrian D TomHenrik ZetterbergMarissa ZwanCraig W RitchiePhilip ScheltensGerald LuscanAnthony J BrookesPieter Jelle Vissernull null

Published in: Alzheimer's research & therapy (2020)

Numbers needed to prescreen varied greatly between settings. Understanding how common AD risk factors link to study participation and amyloid positivity is informative for recruitment strategy of studies on secondary prevention of AD.

Keyphrases

risk factors
mild cognitive impairment
study protocol
cognitive decline
physical activity
randomized controlled trial
cognitive impairment